Metropolis Healthcare Limited
Franklin Templeton Mutual Fund bought 7,42,409 shares of Metropolis Healthcare Limited through the open market. This purchase increased its stake from 4.74% to 5.10%, crossing the 5% disclosure threshold.
One of India's leading diagnostics companies, Metropolis Healthcare operates an extensive chain of diagnostic centres providing pathology and radiology services across multiple regions. The company maintains a widespread presence in India, South Asia, Africa, and the Middle East, offering comprehensive laboratory testing and imaging solutions to patients and healthcare providers. Its network focuses on delivering accurate diagnostics and quality healthcare services through modern facilities and trained professionals.
Indian arm of Franklin Templeton Investments, a global AMC with over USD 1.5 trillion in assets worldwide. Manages over Rs 1.2 lakh crore in India. Navigated a significant setback when six debt schemes were wound up in April 2020 due to illiquid credit exposure, with full investor capital recovered by 2022. Equity franchise led by CIO Anand Radhakrishnan has maintained consistent performance through the volatility.